HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity.

AuthorsS Segal, J Cooper, J Bolognia
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 43 Issue 3 Pg. 558-9 (Sep 2000) ISSN: 0190-9622 [Print] United States
PMID10954677 (Publication Type: Case Reports, Letter)
Chemical References
  • Anabolic Agents
  • Stanozolol
  • Oxandrolone
Topics
  • Anabolic Agents (adverse effects, therapeutic use)
  • Chemical and Drug Induced Liver Injury
  • Female
  • Humans
  • Hyperpigmentation (etiology, pathology)
  • Middle Aged
  • Oxandrolone (therapeutic use)
  • Scleroderma, Localized (drug therapy, pathology)
  • Stanozolol (adverse effects, therapeutic use)
  • Venous Insufficiency (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: